pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Biostatistician Martin Kulldorff Criticizes NIH Gatekeepers Over Measles Claims

Oct 29, 2026·read at STAT ↗Neutral

Martin Kulldorff, a biostatistician known for his opposition to Covid lockdowns, delivered a lecture at the National Institutes of Health in which he challenged the role of scientific gatekeepers.

He asserted that the recent rise in measles cases can be traced to lockdown policies, a viewpoint that many experts consider highly contested.

The presentation was part of a broader health news roundup that also referenced political figures and upcoming conferences, but Kulldorff’s remarks on scientific oversight were the central focus.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Martin Kulldorff critiques scientific gatekeepers at NIH lecture”

read at STAT ↗
1,342 words · retrieved 43m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health
topics
Oncology4Breast Cancer3Peptide Therapeutic3Psychiatry & CNS2ApprovalVaccines

related stories

  • 1h agoLENZ cuts 75% of staff as third quarter earnings disappointBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 4Scientists uncover a new hiding spot for HIVSTAT
  • May 12Dr Parikh on the Feasibility and Importance of Immunotherapy Trials in Anal Canceronclive
  • May 11MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumorsonclive